TriNav

DEVICE2 trials

Sponsors

Dana-Farber Cancer Institute, Massachusetts General Hospital

Conditions

Liver CancerUterine BleedingUterine Fibroid

Phase 4

Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies

WithdrawnNCT02853500

Dana-Farber Cancer InstituteLiver Cancer

Start: 2016-07-31End: 2025-02-03Updated: 2025-02-05

Unknown Phase

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization

TerminatedNCT06106633

Massachusetts General HospitalUterine Bleeding, Uterine Fibroid

Start: 2023-02-09End: 2025-01-20Updated: 2025-04-24